HomeInsightsStock Comparison

Advanced Enzyme Technologies Ltd vs Oxygenta Pharmaceutical Ltd Stock Comparison

Advanced Enzyme Technologies Ltd vs Oxygenta Pharmaceutical Ltd Stock Comparison

Last Updated on: Aug 02, 2025

Key Highlights

  • The Latest Trading Price of Advanced Enzyme Technologies Ltd is ₹ 360.25 as of 01 Aug 15:30.
  • The P/E Ratio of Advanced Enzyme Technologies Ltd changed from 12.4 on March 2020 to 23.8 on March 2025 . This represents a CAGR of 11.48% over 6 yearsThe P/E Ratio of Oxygenta Pharmaceutical Ltd changed from 0 on March 2020 to 0 on March 2025 . This represents a CAGR of 0.0% over 6 years.
  • The Market Cap of Advanced Enzyme Technologies Ltd changed from ₹ 1598 crore on March 2020 to ₹ 3120 crore on March 2025 . This represents a CAGR of 11.79% over 6 yearsThe Market Cap of Oxygenta Pharmaceutical Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 6 years.
  • The revenue of Advanced Enzyme Technologies Ltd for the Mar '25 is ₹ 175.92 crore as compare to the Dec '24 revenue of ₹ 176.8 crore. This represent the decline of -0.5% The revenue of Oxygenta Pharmaceutical Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0%.
  • The ebitda of Advanced Enzyme Technologies Ltd for the Mar '25 is ₹ 54.35 crore as compare to the Dec '24 ebitda of ₹ 62.94 crore. This represent the decline of -13.65% The ebitda of Oxygenta Pharmaceutical Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0%.
  • The net profit of Advanced Enzyme Technologies Ltd changed from ₹ 29.38 crore to ₹ 26.73 crore over 8 quarters. This represents a CAGR of -4.62% The net profit of Oxygenta Pharmaceutical Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% .
  • The Dividend Payout of Advanced Enzyme Technologies Ltd changed from 11.56 % on March 2020 to 56.81 % on March 2025 . This represents a CAGR of 30.39% over 6 yearsThe Dividend Payout of Oxygenta Pharmaceutical Ltd changed from 0 % on March 2020 to 0 % on March 2025 . This represents a CAGR of 0.0% over 6 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Advanced Enzyme Technologies Ltd

  • Advanced Enzyme Technologies Limited (AETL) is largest Indian enzyme company that transformed business globally in the manufacturing and sale of enzymes.
  • The Company was incorporated, as a Private Company on March 15, 1989 as 'Advanced Biochemicals Private Limited' in Maharashtra.
  • It thereafter converted the status into a Public Company and the name of the Company was changed to Advanced Biochemicals Limited on May 28, 1992 and further was changed to Advanced Enzyme Technologies Limited via fresh Certificate of Incorporation at RoC, Mumbai on August 19, 2005. In 2011, the company took over Cal-India Foods International, giving the company direct presence in USA. In 2012, the company took over Advanced Supplementary Technologies Corporation for consolidating its presence in USA. Advanced Enzyme Technologies Limited came out with its Initial Public Offer (IPO) of 4,594,875 Equity shares of Rs 10 each at an issue price of Rs 896 per Equity share ( Rs 810 per Equity share for eligible employees), consisting of fresh issue of 560,405 Equity shares and an Offer for Sale of 4,034,470 Equity shares by Selling Shareholders.

About Oxygenta Pharmaceutical Ltd

  • Oxygenta Pharmaceutical Limited (Formerly known S S Organics Ltd) was incorporated as Private Limited Company in year 1990 and converted into a Limited Company in 1993, with the objective of carrying on the business of manufacturing all classes and kinds of Drugs including Pharmaceutical preparation, and Organic Fine Chemicals.
  • Later, the Company changed its name from S.S. Organics Ltd. to Oxygenta Pharmaceutical Limited in 2021-22. The Company is strong in manufacturing of anti ulcerative and anti bacterial drugs.
  • The Company is doing contract manufacturing work for APL and also having its own production.
  • The Company is engaged in manufacture of bulk drugs.
  • It manufactures a wide range of new generation quinolones, antiasthmatic, antiulcerant, and anti-inflammatory drugs.

Advanced Enzyme Technologies Ltd News Hub

News

Advanced Enzyme Techs. to announce Quarterly Result

Advanced Enzyme Techs. will hold a meeting of the Board of Directors of the Company on 2 A...

Read more

26 Jul 2025 10:03

News

Board of Advanced Enzyme Techs. recommends final dividend

Advanced Enzyme Techs. announced that the Board of Directors of the Company at its meeting...

Read more

13 May 2025 14:29

News

Board of Advanced Enzyme Techs. recommends interim dividend

Advanced Enzyme Techs. announced that the Board of Directors of the Company at its meeting...

Read more

13 May 2025 14:29

News

Advanced Enzyme Techs. to convene AGM

Advanced Enzyme Techs. announced that the 36th Annual General Meeting(AGM) of the company ...

Read more

13 May 2025 17:04

News

Advanced Enzyme Techs. to declare Quarterly Results

Advanced Enzyme Techs. will hold a meeting of the Board of Directors of the Company on 13 ...

Read more

08 May 2025 11:18

News

Advanced Enzyme Techs. to declare Quarterly Results

Advanced Enzyme Techs. will hold a meeting of the Board of Directors of the Company on 13 ...

Read more

07 May 2025 11:26

Oxygenta Pharmaceutical Ltd News Hub

News

Oxygenta Pharmaceutical to discuss results

Oxygenta Pharmaceutical will hold a meeting of the Board of Directors of the Company on 30...

Read more

27 May 2025 16:54

News

Oxygenta Pharmaceutical to convene board meeting

Oxygenta Pharmaceutical will hold a meeting of the Board of Directors of the Company on 14...

Read more

11 Feb 2025 14:01

News

Oxygenta Pharmaceutical announces board meeting date

Oxygenta Pharmaceutical will hold a meeting of the Board of Directors of the Company on 14...

Read more

10 Feb 2025 10:03

News

Oxygenta Pharmaceutical announces board meeting date

Oxygenta Pharmaceutical will hold a meeting of the Board of Directors of the Company on 14...

Read more

11 Nov 2024 11:06

News

Oxygenta Pharmaceutical schedules AGM

Oxygenta Pharmaceutical announced that the 31th Annual General Meeting (AGM) of the compan...

Read more

18 Sep 2024 10:58

News

Oxygenta Pharmaceutical to discuss results

Oxygenta Pharmaceutical will hold a meeting of the Board of Directors of the Company on 14...

Read more

12 Aug 2024 14:50

SWOT Analysis Of Oxygenta Pharmaceutical Ltd

Strength

0

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of Advanced Enzyme Technologies Ltd

Strength

3

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Oxygenta Pharmaceutical Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Advanced Enzyme Technologies Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Advanced Enzyme Technologies Ltd and Oxygenta Pharmaceutical Ltd

Which company has a larger market capitalization, Advanced Enzyme Technologies Ltd or Oxygenta Pharmaceutical Ltd?

Market cap of Advanced Enzyme Technologies Ltd is 4,030 Cr while Market cap of Oxygenta Pharmaceutical Ltd is 373 Cr

What are the key factors driving the stock performance of Advanced Enzyme Technologies Ltd and Oxygenta Pharmaceutical Ltd?

The stock performance of Advanced Enzyme Technologies Ltd and Oxygenta Pharmaceutical Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Advanced Enzyme Technologies Ltd and Oxygenta Pharmaceutical Ltd?

As of August 2, 2025, the Advanced Enzyme Technologies Ltd stock price is INR ₹360.25. On the other hand, Oxygenta Pharmaceutical Ltd stock price is INR ₹101.1.

How do dividend payouts of Advanced Enzyme Technologies Ltd and Oxygenta Pharmaceutical Ltd compare?

To compare the dividend payouts of Advanced Enzyme Technologies Ltd and Oxygenta Pharmaceutical Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions